This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated CENPF Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-CENPF WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~357.5 kDa | |
| Observed band | ~358 kDa | |
| Gel | 5–20% (catalog A03311-1) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The A03311-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela (catalog A03311-1) |
| Gel % | 5–20% (catalog A03311-1) |
| Load | 30 ug; reducing conditions (catalog A03311-1) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A03311-1) |
| Membrane | nitrocellulose membrane (catalog A03311-1) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog A03311-1) |
| Primary antibody | A03311-1 · 0.5 μg/mL (catalog A03311-1) |
| Primary incubation | overnight at 4°C (catalog A03311-1) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog A03311-1) |
| Secondary incubation | 1.5 hour at RT (catalog A03311-1) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog A03311-1) |
| Detection | ECL (catalog A03311-1) |
CENPF is predicted at 357.5 kDa and observed near 358 kDa; the small difference has no established biological cause.
| Band at approximately 358 kDa in whole-cell lysate | matches the reported CENPF band and its 357.5 kDa predicted mass |
| Band just below the precursor position | could reflect removal of the three-residue C-terminal propeptide; identity needs confirmation |
| Closely spaced bands near 358 kDa | could reflect different phosphorylation states; distinct migration is not established |
| Little or no band in a nucleolar fraction | fits the reported exclusion of CENPF from the nucleolus |
| UniProt predicted mass | places the full-length protein near 357.5 kDa; the reported band is approximately 358 kDa |
| 3114-residue sequence | contributes to the large predicted precursor mass |
| C-terminal propeptide at residues 3112–3114 | cleavage would make the mature protein only slightly smaller than the precursor |
| Documented phosphorylation sites | could affect apparent mobility, but a measurable shift is not established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | inefficient detection or transfer of this large protein | check transfer near 358 kDa and compare with a positive whole-cell lysate |
| Band higher than expected | identity or migration of the high-mass band is uncertain | check the high-mass ladder and confirm with an independent CENPF antibody |
| Band lower than expected | the three-residue propeptide cannot explain a large size difference | check for degradation and confirm the band with an independent CENPF antibody |
| Multiple bands | phosphorylation states are possible, but distinct band migration is unproven | compare phosphatase-treated and untreated samples and confirm band identity |
| Weak or no signal | a 358 kDa protein may transfer inefficiently | inspect transfer at high molecular weights and use a positive lysate |
| Fragments below expected size | sample degradation is possible; fragment masses are not supplied | prepare fresh lysate with protease inhibitors and compare antibody epitopes |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | germinal center cells | Medium | Protein (IHC) | HPA → |
| Colon | enterocytes | Medium | Protein (IHC) | HPA → |
| Duodenum | enterocytes | Medium | Protein (IHC) | HPA → |
| Endometrium | glandular cells | Medium | Protein (IHC) | HPA → |
| Epididymis | glandular cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for CENPF, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-CENPF antibody, A03311-1, with a Western blot image from human HeLa whole-cell lysate. The caption reports a band near the expected 358 kDa using 0.5 μg/mL primary antibody. No publication or independent validation evidence is supplied.
Which to pick: A03311-1 is the only listed option. Its stated reactivity is human, and its WB image uses human HeLa lysate; the caption reports a 358 kDa band. Evidence for other samples or species is not supplied.